Status:
COMPLETED
Prediction of BK Virus Reactivation in Kidney Transplant Recipient
Lead Sponsor:
King Chulalongkorn Memorial Hospital
Conditions:
Kidney Transplant Infection
BK Virus Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There has been no effective predicting tool to accurately predict BKV reactivation after kidney transplantation. The aim is to elucidate the use of flow cytometric analysis for both intracellular cyto...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- New kidney transplantation cases (either living donor or deceased donor transplantation)
- Age ≥ 18 years old
- Agree to give a permission to blood sampling post-transplantation, and at the time of BK viremia.
- Exclusion criteria:
- Pregnant
- Primary non-function of kidney allograft (i.e. kidney allograft never function).
Exclusion
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06219616
Start Date
May 1 2023
End Date
May 31 2025
Last Update
December 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Chulalongkorn Memorial Hospital
Bangkok, Bangkok, Thailand, 10330